Cargando…

C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes

INTRODUCTION: There is a paucity of clinical data on C1q nephropathy (C1qN) in children in India and Southeast Asia. This is the first detailed analysis conducted to elucidate the prevalence, clinicopathological profile, and response to different immunosuppressives in children with C1qN in India. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaur, Saumil, Patrick, Reeba, Vankalakunti, Mahesha, Phadke, Kishore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916143/
https://www.ncbi.nlm.nih.gov/pubmed/35283565
http://dx.doi.org/10.4103/ijn.IJN_578_20
_version_ 1784668223968378880
author Gaur, Saumil
Patrick, Reeba
Vankalakunti, Mahesha
Phadke, Kishore
author_facet Gaur, Saumil
Patrick, Reeba
Vankalakunti, Mahesha
Phadke, Kishore
author_sort Gaur, Saumil
collection PubMed
description INTRODUCTION: There is a paucity of clinical data on C1q nephropathy (C1qN) in children in India and Southeast Asia. This is the first detailed analysis conducted to elucidate the prevalence, clinicopathological profile, and response to different immunosuppressives in children with C1qN in India. MATERIALS AND METHODS: Detailed demographic profile, clinical features, urine and blood chemistries, kidney biopsy, and response to different immunosuppressives of the study participants were analyzed between August 2015 and October 2020 for steroid-dependent/-resistant nephrotic syndrome (NS). RESULTS: C1qN was diagnosed in 16 (14.13%) of 113 children who underwent biopsy for steroid-dependent/-resistant NS. The mean age was 44 months (range 18–99 months) and male and female number was 12 (75%) and four (25%), respectively, and mean follow-up was 3.5 years. Eight (50%) had coexistent minimal-change nephrotic syndrome (MCNS) pattern, seven (43.7%) had focal segmental glomerulosclerosis (FSGS), and one (6.2%) had diffuse mesangial hypercellularity. Thirteen children had complete follow-up, of which eight (61.5%) and four (30.7%) cases presented as steroid-dependent and primary steroid-resistant NS, respectively, whereas one (7.6%) had joint pain with rashes. At presentation, seven (53.8%) had hypertension, 12 (92.3%) had nephrotic range proteinuria, and six cases (46.1%) had hematuria. Nine (75%) of 12 cases achieved complete remission with calcineurin inhibitor (CNI) therapy, and two were non responders, one was a partial responder, and one responded to mycophenolate. Of six FSGS cases, four had complete remission, one had partial remission, and one was in non-remission. Of six cases with MCNS, five had complete remission and one was in non-remission. Renal functions remained normal in all except one case who had progression to chronic kidney disease Stage 3. CONCLUSION: One out of seven children with difficult NS can have underlying C1qN. CNIs are most beneficial to attain and maintain remission. Renal functions remain normal in the majority. Along with C1q deposits, MCNS and FSGS patterns are seen equally and respond almost similarly to CNIs.
format Online
Article
Text
id pubmed-8916143
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-89161432022-03-12 C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes Gaur, Saumil Patrick, Reeba Vankalakunti, Mahesha Phadke, Kishore Indian J Nephrol Original Article INTRODUCTION: There is a paucity of clinical data on C1q nephropathy (C1qN) in children in India and Southeast Asia. This is the first detailed analysis conducted to elucidate the prevalence, clinicopathological profile, and response to different immunosuppressives in children with C1qN in India. MATERIALS AND METHODS: Detailed demographic profile, clinical features, urine and blood chemistries, kidney biopsy, and response to different immunosuppressives of the study participants were analyzed between August 2015 and October 2020 for steroid-dependent/-resistant nephrotic syndrome (NS). RESULTS: C1qN was diagnosed in 16 (14.13%) of 113 children who underwent biopsy for steroid-dependent/-resistant NS. The mean age was 44 months (range 18–99 months) and male and female number was 12 (75%) and four (25%), respectively, and mean follow-up was 3.5 years. Eight (50%) had coexistent minimal-change nephrotic syndrome (MCNS) pattern, seven (43.7%) had focal segmental glomerulosclerosis (FSGS), and one (6.2%) had diffuse mesangial hypercellularity. Thirteen children had complete follow-up, of which eight (61.5%) and four (30.7%) cases presented as steroid-dependent and primary steroid-resistant NS, respectively, whereas one (7.6%) had joint pain with rashes. At presentation, seven (53.8%) had hypertension, 12 (92.3%) had nephrotic range proteinuria, and six cases (46.1%) had hematuria. Nine (75%) of 12 cases achieved complete remission with calcineurin inhibitor (CNI) therapy, and two were non responders, one was a partial responder, and one responded to mycophenolate. Of six FSGS cases, four had complete remission, one had partial remission, and one was in non-remission. Of six cases with MCNS, five had complete remission and one was in non-remission. Renal functions remained normal in all except one case who had progression to chronic kidney disease Stage 3. CONCLUSION: One out of seven children with difficult NS can have underlying C1qN. CNIs are most beneficial to attain and maintain remission. Renal functions remain normal in the majority. Along with C1q deposits, MCNS and FSGS patterns are seen equally and respond almost similarly to CNIs. Wolters Kluwer - Medknow 2022 2021-11-13 /pmc/articles/PMC8916143/ /pubmed/35283565 http://dx.doi.org/10.4103/ijn.IJN_578_20 Text en Copyright: © 2021 Indian Journal of Nephrology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Gaur, Saumil
Patrick, Reeba
Vankalakunti, Mahesha
Phadke, Kishore
C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes
title C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes
title_full C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes
title_fullStr C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes
title_full_unstemmed C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes
title_short C1q Nephropathy in Children with Nephrotic Syndrome: Treatment Strategies and Outcomes
title_sort c1q nephropathy in children with nephrotic syndrome: treatment strategies and outcomes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916143/
https://www.ncbi.nlm.nih.gov/pubmed/35283565
http://dx.doi.org/10.4103/ijn.IJN_578_20
work_keys_str_mv AT gaursaumil c1qnephropathyinchildrenwithnephroticsyndrometreatmentstrategiesandoutcomes
AT patrickreeba c1qnephropathyinchildrenwithnephroticsyndrometreatmentstrategiesandoutcomes
AT vankalakuntimahesha c1qnephropathyinchildrenwithnephroticsyndrometreatmentstrategiesandoutcomes
AT phadkekishore c1qnephropathyinchildrenwithnephroticsyndrometreatmentstrategiesandoutcomes